300 filings
Page 3 of 15
8-K
rnh71t hkvj8s3mt223
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
cstfqhb38
5 Aug 21
Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates
7:02am
8-K
c8g 9we5gyeac
2 Aug 21
Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease
7:00am
8-K
tibaq7rxaagnn kiv2
14 Jun 21
Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors
7:27am
8-K
ixr69za ti355hjdfr9d
8 Jun 21
Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
7:00am
8-K
s1806q9ylobl92
10 May 21
Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates
7:00am
8-K
h9g1anffy 1f
3 May 21
Amicus Therapeutics Announces Successful Pre-BLA Meeting with U.S. FDA for AT-GAA for the Treatment of Pompe Disease
7:01am
8-K
1icndilrktas41fsehe
1 Mar 21
Amicus Therapeutics Announces Full-Year 2020 Financial Results and Corporate Updates
12:00am
8-K
pwcgzb 4tilkg1434n
11 Feb 21
Rolling BLA submission for AT-GAA planned for completion in Q2 and other global regulatory submissions for approval expected throughout 2021
4:01pm
8-K
ac8vht
8 Feb 21
Initial Data Suggest Early Signs of Disease Stabilization in Children with Fatal Neurologic Disease
2:30pm
8-K
rl41ad4m
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
wlzzh6 21vc
2 Dec 20
Amicus Therapeutics Appoints Michael A. Kelly to its Board of Directors
7:00am
8-K
pofl136xqqb42j4
5 Nov 20
Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
7:00am
8-K
9g94wwb
10 Aug 20
Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
7:00am
8-K
mubf1suwixw0ejtnl
30 Jul 20
Termination of a Material Definitive Agreement
7:13pm
8-K
qcnwyp3 72
17 Jul 20
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
7:33am
8-K
lxjzk
8 Jun 20
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
z1fn gl6np9c8
14 May 20
Other Events
7:00am
8-K
qtu19 6h1llzhqb
8 May 20
Amicus Therapeutics Announces Virtual 2020 Annual Meeting of Shareholders
7:00am
8-K
wo82mcjomr
7 May 20
Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
7:00am